PMS60 Patient-Reported Outcomes In Surgical Practice: Preoperative Predictors Of Poor Outcome Following Primary Total Knee Arthroplasty  by Kirkness, C.S. et al.
 VA L U E  I N  H E A LT H  1 7  ( 2 0 1 4 )  A 1 - A 2 9 5  A51
12 times more likely to be NWH compared to those walking at normal speed (Odds 
Ratio [OR]: 12.4 95% Confidence Interval [CI] 6.0 -25.6; p< 0.001), after controlling for 
age, gender, race, education, body mass index (BMI), income, and comorbidities. 
Further, the contribution of comorbidities in the model was significantly (p< 0.001) 
weakened when WS entered the model. ConClusions: Walking speed was an 
independent predictor of NWH status among community dwelling women and 
may be useful in the work setting to identify those at high risk of health related job 
loss. Further evaluation of the longitudinal predictive capability of WS is needed.
PMS58
The ASSeSSMenT Of ShOulder InSTAbIlITy: The develOPMenT And 
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objeCtives: To develop a questionnaire for completion by patients presenting with 
shoulder instability. Methods: A draft 18 item questionnaire was developed using 
themes identified from interviews with patients (n= 20). The draft questionnaire 
was then tested on further groups of 20 patients attending an outpatient clinic, to 
which they had been referred with instability of the shoulder. Following modifica-
tion resulting from patient feedback, the revised 12 item questionnaire was then 
tested in a prospective study of consecutive patients attending out-patient clinics 
for shoulder instability (n= 98). Patients completed patient-reported and clinical 
assessments pre-intervention (physiotherapy or surgery) and again at 6 months 
following treatment. The questionnaire was evaluated regarding its internal consist-
ency, reproducibility, validity and responsiveness (sensitivity to change). Results: 
The results provide evidence of good measurement properties of the questionnaire: 
Internal consistency - Cronbach’s alpha was 0.91 at the pre-treatment assessment (n 
= 92) and 0.92 at follow-up (n = 64). Reproducibility - In the test-retest sample (n = 
34), the correlation between the total scores for the questionnaire was high (r = 0.97, 
p < 0.0001), coefficient of reliability 5.7. Construct validity - The new questionnaire 
correlated well with the Constant and Rowe clinical scores both before operation 
and at the six-month follow-up. It also agreed significantly with the related parts 
of the SF36, particularly in physical function and pain. Responsiveness – The new 
questionnaire and the Rowe clinical score (but not the Constant) each achieved a 
large standardised effect size (≥ 0.8) that surpassed values obtained on relevant 
SF36 domains. ConClusions: We developed and tested a short patient-reported 
12-item questionnaire (‘score’) which patients have found easy to complete and 
which provides reliable, valid and responsive information as to their perception 
of shoulder instability.
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chArAcTerISTIcS Of PATIenTS WITh rheuMATOId ArThrITIS SAMPled 
frOM A PATIenT AdvOcAcy OrgAnIzATIOn verSuS A cOnSuMer PAnel: 
IMPlIcATIOnS fOr PATIenT-cenTered reSeArch
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objeCtives: Much information about the disease experience can only be obtained 
directly from patients. However, biases may be introduced to patient-reported 
research depending on the source of the sample. This analysis seeks to identify 
differences in demographic and disease characteristics between samples of patients 
with rheumatoid arthritis (RA) recruited through an advocacy organization and 
a consumer panel. Methods: Data were collected online from two groups of 
patients through self-administered questionnaires. Patients were recruited through 
the patient advocacy organization CreakyJoints and the Lightspeed Research con-
sumer panel. Patients in both groups were U.S. adults (aged ≥ 18), diagnosed with 
RA, currently treated by a rheumatologist with disease modifying anti-rheumatic 
drugs (DMARDs), and with no history of biologic use but had discussed biolog-
ics with their physician. Results: A total of 243 patients completed the study. Of 
these, 101 were from the advocacy organization and 142 were from the consumer 
panel. Patients from the advocacy organization were younger (mean age, 46 vs. 57) 
and more likely to be female (93% vs. 80%), employed (53% vs. 31%), have a college 
degree (59% vs. 43%), and have commercial insurance (70% vs. 51%) than patients 
from the consumer panel (p< 0.05 for all comparisons). Patients from the advocacy 
organization also began experiencing RA symptoms more recently (mean years 
since symptom development, 10 vs. 15) and were more likely to be diagnosed by a 
rheumatologist (73% vs. 51%), have a caregiver (47% vs. 24%), and be non-adherent 
with medication (61% vs. 42%) than patients from the consumer panel (p< 0.05 for all 
comparisons). ConClusions: Members of patient advocacy organizations and con-
sumer panels can differ demographically and in their disease characteristics. The 
potential impact of these differences on study results should be considered when 
developing a sampling and recruitment plan for patient-centered survey research.
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objeCtives: Identifying those at highest risk of poor outcomes is critical to popu-
lation health management. The purpose of this study was to identify preoperative 
factors and comorbidities that are associated with those at risk of poor patient-
reported physical function recovery one year following total knee arthroplasty 
(TKA). Methods: Primary TKA unilateral procedures from a patient-reported total 
However, further methodological research is needed to achieve standardization 
of procedures.
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objeCtives: The aim of this study was to measure what matters most in WTP for 
a treatment, the patients’ perception of their health status, their ability to pay, or a 
combination of both. Methods: 395 US patients diagnosed with either psoriasis 
(n= 151) or psoriatic arthritis (n= 247) completed a questionnaire as part of a broader 
survey of treatment of psoriasis/psoriatic arthritis in the US. The questionnaire 
included the EQ-5D-5L instrument and accompanying VAS. Patients were addition-
ally asked to indicate by reference to the EQ-5D VAS scale the amount of money 
per month they would be willing to pay for treatments that would improve their 
health status by 10 points, retain their current health and prevent a decline in 
health status by 10 points. Annual household income information was also reported 
by patients. Patients were split into 3 equal groups based on their VAS. Results: 
Household income was a better predictor of WTP for a treatment; those patients 
with an annual income of less than $25000 were willing to pay the least (p< 0,001), 
whereas patients with an annual household income over $75000 would pay most 
(p< 0,001). Patients within the lowest VAS segment were prepared to pay significantly 
more for an improvement in their health status than patients within the other seg-
ments (p< 0,003). No significant differences were noted between groups to either 
retain health status or avoid health decline. For predicting WTP for an improvement 
in health status, a combination of low yearly income (< $25000) and the EQ-5D VAS 
was the best (sig < 0.001); WTP for a 10 VAS point improvement = $142 + (-$39,9*Low 
Income) + (-$0,7*VAS score). ConClusions: Both ability to pay and health status 
are valid predictors of willingness to pay for a treatment. Yet ability to pay is a better 
overall predictor of willingness to pay than HRQoL.
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objeCtives: To evaluate the benefits in functional status and labor productivity 
of tofacitinib in patients with inadequate response to a non-biological DMARD vs 
anti-TNF in Colombia. Methods: The response to treatment was assessed by the 
change from baseline in the Health Assessment Questionnaire-Disability Index 
(HAQ-DI) from baseline and works lost productivity: absenteeism and presentee-
ism (productivity reduction ≥ 50%) due patient’s functional status, as reported by 
Chaparro del Moral R. 2012 and Hazes JM. 2010 who measured absenteeism accord-
ing to functional status regardless of treatment received. Comparison between anti-
TNF and tofacitinib (5mg BID) was done directly to adalimumab (heat-to-heat study) 
and indirectly (Bucher´s indirect comparisons adjusted method) vs other anti-TNF 
available in Colombia (certolizumab, etanercept, golimumab and infliximab) using 
methotrexate as reference therapy. A discrete event model that simulates six cohorts 
of 1,000 patients (each per treatment option) was developed; productivity hours 
lost was projected according to HAQ level (< 0.5; 0.5-0.87; > 0.87), during 52 weeks 
horizon. Variations in HAQ levels (basal and weekly mean chance), absenteeism 
and presenteeism hours were probabilistically generated assuming a normal dis-
tribution. The results obtained with the anti-TNF’s are grouped and weighted given 
their market share as reported in the SISMED by the Health Ministry. Results: 
Improvement in HAQ-DI score at 3, 6, 9 and 12 months from baseline with tofaci-
tinib and anti -TNF were 61.9, 48.7, 65.2 and 53.2%; and, 49.5, 42.7, 57.1 and 47.1%, 
respectively (t-test at 52 weeks, p< 0.001). As result of these reductions, the hours 
of absenteeism/presenteeism losses along the 52-week horizon were obtained, at 
last observation week: 2.72/2.67 and 4.04/7.23 hours with tofacitinib and anti-TNF 
respectively. ConClusions: The superior reduction in HAQ-DI scale at 52 weeks 
obtained with Tofacitinib in patients with inadequate response to a non-biological 
DMARD results in a greater reduction in work lost productivity, presenteeism and 
absenteeism, compared to anti-TNF available in Colombia.
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WAlKIng SPeed PredIcTS WOrK STATuS due TO heAlTh In cOMMunITy 
dWellIng WOMen: The OSTeOArThrITIS InITIATIve (OAI)
Kirkness C.S., Ren J.
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objeCtives: Early identification of declining health in working adults with osteo-
arthritis (OA) may allow targeted interventions that prevent health related job loss. 
Usual walking speed(WS) is a predictor of health status in adults ≥ 65 years41and 
may also be a useful simple predictor of work status in younger adults with OA. 
The study purpose was to determine whether WS is an independent predictor 
of work status in women with or at risk for osteoarthritis adjusting for covari-
ates. Methods: Participants were 2,634 women (23% African American) age 45-79 
years with baseline WS (Self-selected 20 meters [m]) in the OAI study. Logistic 
regression examined WS as a predictor of work status (working versus not working 
due to health [NWH]) for those walking at slow (< 1.10 meters/second[s]), moderate 
(1.1-1.29 m/s) and normal (> 1.3 m/s) speeds, adjusting for demographics and other 
confounders. Results: Of the 2,634 women (mean age 60.0, Standard Deviation 
[SD] 9.1, years), 57.9% (1,533) were working, 36.0% (952) were not working for other 
reasons and 5.6% (149) were NWH. WS was significantly faster in those working 
compared to those NWH, (mean speed 1.33 m/s vs. 1.08 m/s; p< 0.001). Compared to 
women with normal WS (> 1.3 m/s), those considered slow walkers (WS < 1.10) were 
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objeCtives: Little is known about the health-related quality of life (HRQoL) for 
rheumatoid arthritis (RA) in Korean population. Several studies discovered quality of 
life of RA patients in Korea using localized resources, not nationwide one. The aim of 
this study was to estimate HRQoL of Korean RA patients and also discover education 
and treatment status of them based on nationally representative data. Methods: 
This study is a cross-sectional analysis of adults who participated in 4th (2007-2009) 
and 55th (2010-2011) Korean National Health and Nutritional Examination Survey 
(total, 42,347 participants). HRQoL was measured by EuroQol five-dimension (EQ-
5D) and its mean score in Korean RA patients was investigated and compared with 
normal population. Multivariate linear regression was performed at p-value of 0.05 
with the use of SAS software, version 9.2. Results: Among 42,347 participants, 
679 participants, 1.88% had diagnosed of RA and their mean EQ-5D score was 0.82. 
Among 679 RA patients, 288 patients (42.42%) have been treated and 25 patients 
(3.68%) educated in arthritis. The mean EQ-5D score of normal population was 0.93. 
We found that RA patients in Korea had significantly lower EQ-5D score (0.028, 
p-value= 0.002) compared with that of normal population in Korea, after control-
ling for age, sex, body mass index (BMI), education, house income, marital status, 
smoking, alcohol, RA treatment, and education in arthritis. Compared EQ-5D score 
of RA patients who were in treatment to those not in treatment, no statistically 
significant difference was found. ConClusions: Less than 50% of RA patients 
were treated and only 4% were educated about their disease. RA is found to be 
negatively related with HRQoL in Korea population based on nationwide data. This 
study discovered nationwide information on RA: education and treatment status 
of RA patients as well as difference of HRQoL scores between RA patients and non-
RA patients in Korea.
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objeCtives: Limited information currently exists regarding the additional influ-
ence of depression on health-related quality of life (HRQOL) and disability sta-
tus among adults with arthritis. This study aimed to determine the relationship 
between depression, HRQOL and disability status of adults with arthritis in the 
United States (US). Methods: A cross-sectional design using the 2011 Behavioral 
Risk Factor Surveillance System (BRFSS) data was utilized. The study sample com-
prised of adults (≥ 18 years) with arthritis. Multivariate logistic regression models 
were fitted to the data to examine the association between depression and dif-
ferent components of HRQOL (physical health, mental health, activity limitation 
due to poor physical/mental health, and general health status), and disability 
status among adults with arthritis. Survey analyses were conducted using SASv9.3 
(PROC SURVEY procedures). Results: The study sample comprised of 168,483 
individuals with arthritis, of which 45,758 were also diagnosed with depression. 
Adults with arthritis and depression were 84% less likely to report better mental 
health (< 14 mentally unhealthy days) and 37% less likely to report better physical 
health as compared to those with arthritis only, after controlling for demographics 
and health-related covariates. Adults with arthritis and depression were 41% less 
likely to report good health status as compared to those with arthritis only. Adults 
with arthritis and depression were 1.4 times more likely to be disabled as com-
pared to adults with arthritis only. The estimated odds of being disabled were 64% 
lower among adults with arthritis who reported being in good health as compared 
to those in poor health. ConClusions: The results of the study suggest that 
depression among adults with arthritis is associated with reduced HRQOL. 
Screening for depression can be incorporated in routine clinical care of adults 
with arthritis so that early diagnosis of depression can result in improvement 
in their HRQOL.
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objeCtives: To analyze the impact on health status and disease specific quality of 
life with tofacitinib for rheumatoid arthritis in patients with inadequate response 
to a non-biological DMARD vs anti-TNF in Colombia. Methods: We use the change 
from baseline in the Health Assessment Questionnaire-Disability Index (HAQ-DI) as 
effectiveness measure and grouped by disease severity levels (0.5 difference) in order 
to infer the changes in Quality of Live obtained with Tofacitinib and the anti-TNF 
available in Colombia (adalimumab, certolizumab, etanercept, golimumab and inf-
liximab). Comparison between anti-TNF and tofacitinib (5mg BID) was done directly 
to adalimumab (heat-to-heat study) and indirectly (Bucher´s indirect comparisons 
adjusted method) using methotrexate as reference therapy against the rest anti-TNF. 
The relationship between the health status and Quality of life improvement were 
taken from Péntek M 2008 and projected at 52 weeks through a discrete event model 
that simulates six cohorts of 1,000 patients (each per treatment option). The model´s 
result were tested by randomly changing the HAQ levels (basal and weekly mean 
change) and utility gains assuming a normal distribution. The results obtained with 
the anti-TNF’s were grouped and weighted given their market share as reported in 
the SISMED by the Health Ministry. Results: Percent reduction in HAQ-DI score at 
3, 6, 9 and 12 months from baseline were 61.9, 48.7, 65.2 and 53.2% with tofacitinib; 
and 49.5, 42.7, 57.1 and 47.1% with anti–TNF (t test at 52 weeks, p< 0.001). As result 
of these reductions, quality of life at week 52 increased from 0.50 to 0.78 (0.28) with 
tofacitinib and from 0.5 to 0.70 (0.20) with anti-TNF. ConClusions: The superior 
reduction in HAQ-DI scale at 52 weeks obtained with tofacitinib in RA patients with 
inadequate response to a non-biological DMARD results in a greater improvement in 
disease specific quality of life, compared to anti-TNF available in Colombia.
hip and knee arthroplasty registry in a surgical clinical practice were identified 
between 2008 to 2010 and followed over 2 years. Each patient visit was included in 
the analysis. Addionally, preoperative patient and clinical factors were identified 
from the electronic medical record. Hierarchical linear models were used to assess 
patient and clinical risk factors associated with physical function (Physical com-
ponent score of the SF36) in age groups (40-49, 50-69 and ≥ 70 years) over the study 
time. Results: A total of 154 total knee arthroplasties were identified; 63.6% were 
females, average age was 63.7 years (standard deviation [SD] = 10.2, range 41-85 
years), and the average body mass index (BMI) was 31.8 kg/m2 (SD = 7.2). Compared 
to those ≥ 70 years old, the physical function after surgery of those age 40-49 years 
was not significantly different, while those aged 50-69 years old were significantly 
better, in a fully adjusted model (controlling for comorbidities). Patient factors 
associated with lower physical function recovery were back pain (β 3.3, 95% CI 0.81 
- 5.79) and preoperative physical function (β 0.39, CI 0.25 – 0.52). ConClusions: 
Preoperative reporting of previous back pain and low preoperative physical function 
were the only modifiable patient factors significantly associated with low physi-
cal function outcome after surgery. Younger(40-49 year) and older (≥ 70 years age) 
patients had similar levels of physical function after surgery whereas those consid-
ered to be middle-aged (50-69 years) had significantly higher post-surgery function.
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objeCtives: To evaluate everyday disability (in the broad sense of the term) due 
to knee arthritis in a population whose diagnosis has recently been confirmed. 
According to an epidemiological study conducted in France, the prevalence of symp-
tomatic knee arthritis is estimated as 7.6%, about 2 million patients. Methods: 
Prospective, non-interventional evaluation. 100 French doctors (rheumatologists and 
GP) recruited patients who had consulted them spontaneously and for whom knee 
arthritis was diagnosed.The disability generated was evaluated by means of the 
BONe’S questionnaire. Results: 456 subjects were deemed eligible for evaluation. 
The sex ratio favoured women (65%).The average age of the population was 65.16 
± 10.9 years. 35% declared that they were active.The average BMI of the population 
was 27.75 ± 4.9; the proportions for men and women were respectively: 27% and 
34% < 25, 46% and 34% between 25 and 30, 21% and 32% > 30. The mean score of 
the burden was found to be 30.04 ± 17.8. The score differed according to sex: 31.33 
± 16.9 against 28.34 ± 18.9 (p < 0.05). The score also differed according to BMI: 26.1 
± 17.4 if < 25, 30.8 ± 18.1 between 25 and 30 and 33.6 ± 17 if > 30 (p < 0.01). The 
most affected dimensions were autonomy, leisure and psychology. The effect on 
the budget dimension was 6 times greater for active patients compared to inactive 
patients. The monthly expenses to be paid by the patient differed depending on 
the sex: € 31.09 for women and € 23 for men (not significant). ConClusions: This 
evaluation confirms the impact of knee arthritis in the everyday life of subjects 
who suffer from it. 35% of subjects are active, and the negative impact on work is 
liable to grow in view of the ageing of the population and the longer working lives 
in developed countries.
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objeCtives: Item response theory based computerized adaptive testing offers 
opportunity to measure health outcomes efficiently and economically. The 
Cerebral Palsy Computer Adaptive Tests (CP-CATs) are parent-reported question-
naires developed to assess physical functioning in children and adolescents with 
CP. Concurrent validity and reliability of CP-CATs have already been established. 
Prior to using them in research or clinical practice, it is important to examine their 
responsiveness as compared to the standard measure. The Pediatric Outcomes 
Data Collection Instrument (PODCI) is traditionally used to measure health and 
functional outcomes. Children and adolescents with CP often undergo muscu-
loskeletal surgery to improve their functioning and health related quality of life 
(HRQOL), and therefore this serves as an apt paradigm to examine responsiveness 
of CP-CATs for activity, pain and global health with the corresponding PODCI meas-
ures. Methods: Ten sites across U.S. recruited patients two to twenty years of 
age who underwent musculoskeletal surgery between April 2009 and August 2013. 
Parents or other proxy respondents completed the CP-CATs and PODCI preopera-
tively and postoperatively at 6, 12 and 24 months. Change from baseline analyses 
at six months was performed for n= 247-252, at twelve months for n= 211-217 and 
at twenty-four months for n= 120-123 subjects. Effect size (ES) and Standardized 
Response Mean (SRM) values were calculated for the CP-CATs and the comparable 
PODCI measures. Results: Overall, ES and SRM of CP-CATs for activity, pain and 
global health were significantly better than the corresponding PODCI measures 
for mobility, sports, pain and global health at 6 and 12 months. At 24 months, 
CP-Activity CAT was more responsive than PODCI mobility and sports, and CP-Pain 
CAT’s responsiveness was similar to PODCI pain. ConClusions: Results suggest 
that the CP-CATs may be more responsive to functional changes and HRQOL fol-
lowing musculoskeletal surgery in children and adolescents with CP, especially 
in the first 12 months post-surgery.
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